Effect of various antilipolytic compounds on adenyl cyclase and phosphodiesterase activity in isolated fat cells.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D000818:Animals; D004789:Enzyme Activation; D004837:Epinephrine / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D050356:Lipid Metabolism; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D007093:Imidazoles; D007328:Insulin; D009539:Nicotinic Acids; D011433:Propranolol; D010744:Phosphoric Monoester Hydrolases; D000262:Adenylyl Cyclases; D004837:Epinephrine